XML 33 R20.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUE (Tables)
12 Months Ended
Dec. 31, 2018
REVENUE  
Schedule of significant changes in the contract assets

Significant changes in the contract assets balance during the year ended December 31, 2018 was as follows:

 

 

 

 

 

Year Ended December 31, 2018

    

 

 

Outstanding at January 1, 2018

 

$

6,459

Increase (decrease) attributed to:

 

 

  

Transferred to receivables from contract assets recognized

 

 

(5,932)

Product transferred over time

 

 

5,904

Outstanding at December 31, 2018

 

$

6,431

 

Schedule of net sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ending December 31, 2018

 

 

Product/ Service

 

Product

 

 

 

 

 

 

 

 

Transferred Over 

 

Transferred at

 

Noncash

 

Total Net Sales

(in thousands)

    

Time

    

Point in Time

    

Consideration

    

by Market

Aerospace and Defense

 

$

17,263

 

$

232

 

$

819

 

$

18,314

Medical

 

 

39,071

 

 

4,157

 

 

1,854

 

 

45,082

Industrial

 

 

46,950

 

 

821

 

 

2,203

 

 

49,974

Total net sales

 

$

103,284

 

$

5,210

 

$

4,876

 

$

113,370

 

Schedule of consolidated statement of operations and comprehensive income, balance sheet and cash flows, to the pro-forma amounts had the previous guidance been in effect

The following table compares the reported consolidated statement of operations and comprehensive loss, balance sheet and cash flows, as of and for the year ended December 31, 2018, to the pro-forma amounts had the previous guidance been in effect:

 

 

 

 

 

 

 

 

 

 

Year Ending December 31, 2018

 

 

 

 

 

Pro forma as if the

 

 

 

 

 

previous accounting

 

 

 

 

 

guidance was in

Consolidated Statement of Operations

    

As Reported

    

effect

Net Sales

 

$

113,370

 

$

108,522

Cost of Goods Sold

 

 

100,059

 

 

95,249

Gross Profit

 

 

13,311

 

 

13,273

 

 

 

 

 

 

 

Income from Operations

 

 

1,249

 

 

1,211

 

 

 

 

 

 

 

Income Before Income Taxes

 

 

492

 

 

454

 

 

 

 

 

 

 

Income Tax Expense

 

 

326

 

 

326

 

 

 

 

 

 

 

Net Income

 

$

166

 

$

128

 

 

 

 

 

 

 

Net Income Per Common Share - Diluted

 

$

0.06

 

$

0.05

 

 

 

 

 

 

 

 

 

 

As of December 31, 2018

 

 

 

 

 

Pro forma as if the

 

 

 

 

 

previous accounting

 

 

 

 

 

guidance was in

Consolidated Balance Sheet

    

As Reported

    

effect

Assets

 

 

  

 

 

  

Inventories

 

$

17,004

 

$

22,015

Contract Assets

 

$

6,431

 

$

 —

 

 

 

 

 

 

 

Shareholders' Equity

 

 

  

 

 

  

Retained Earnings

 

$

21,090

 

$

19,671

 

 

 

 

 

 

 

 

 

 

Year Ending December 31, 2018

 

    

 

 

    

Pro forma as if the

 

 

 

 

 

previous accounting

 

 

 

 

 

guidance was in

Consolidated Statement of Cash Flows

    

 

As Reported

    

effect

Net Income

 

$

166

 

$

128

Adjustments to Reconcile Net Loss to Net Cash

 

 

  

 

 

  

Provided by Operating Activities

 

 

  

 

 

  

Change in Current Operating Items

 

 

  

 

 

  

Inventories

 

 

(3,875)

 

 

(3,809)

Contract Asset

 

 

28

 

 

 —

 

 

 

 

 

 

 

Net Cash Provided by Operating Activities

 

$

2,444

 

$

2,444